Clinical Trial Update: The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Ave-CRT in newly diagnosed metastatic esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Tumor, Metastatic Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN